FDA DEVICE FACTS
Albumin BCG2
Abbott Ireland Diagnostics Division
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Albumin BCG2 assay is used for the quantitation of albumin in human serum or plasma on the ARCHITECT c System. The Albumin BCG2 assay is to be used as an aid in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys. The Albumin BCG assay is used for the quantitation of albumin in human serum or plasma. Methodology Colorimetric (Bromocresol Green) Same Specimen Type Human serum or plasma Same Assay Principle / Principle of Procedure The Albumin BCG2 procedure is based on the binding of bromocresol green in the assay reagent specifically with albumin in the patient sample to produce a colored complex. The absorbance of the complex at 604 nm is directly proportional to the albumin concentration in the sample. The Albumin BCG procedure is based on the binding of bromocresol green specifically with albumin to produce a colored complex. The absorbance of the complex at 628 nm is directly proportional to the albumin concentration in the sample. Standardization ERM-DA470/IFCC Same Use of Calibrators Yes Same Use of Controls Yes Same a In accordance with FDA Guidance Document “Data for Commercialization of Original Equipment Manufacturer, Secondary and Generic Reagent for Automated Analyzers”, issued June 10, 1996, the assay equivalency study on ARCHITECT c System vs. the original platform, AEROSET, was performed and submitted under K980367/A004 in May 2002. ERM = European Reference Materials Standard Reference Material IFCC - International Federation of Clinical Chemistry and Laboratory Medicine Attachment 2 Albumin BCG2 510(k) Section 5 Page 5-5 Comparison of Subject Device Albumin BCG2 to Predicate Device Albumin BCG (Continued) Characteristics Subject Device Albumin BCG2 (List No. 04T34)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。